Search research articles
Contact Us
Filters
Showing results (41-50 of 141) with videos related to
Page
of 15
Sort By:
Lancet (London, England)
|
August 26, 1998
Neurological efficacy of stavudine, zidovudine, and lamivudine
M Gisslén, B Svennerholm, D Fuchs, et al.
Ugeskrift for Laeger
|
April 15, 2000
[Hand transplantation and implantation of nerve chips. New developments within hand surgery]
L Dahlin, J Fridén, L Hagberg, et al.
AIDS Research and Human Retroviruses
|
January 20, 1996
Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection
M Gisslén, P Fredman, G Norkrans, et al.
Journal of Neuroscience Research
|
August 1, 1989
Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection
M Larsson, L Hagberg, G Norkrans, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1989
Immune status and booster effects of low doses of diphtheria toxoid in Swedish medical personnel
B Björkholm, M Wahl, M Granström, et al.
Infection
|
January 1, 1987
An outbreak of diphtheria among Swedish alcoholics
B Björkholm, S Olling, P Larsson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1985
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections
L Hagberg, D E Briles, C S Edén
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 31, 1999
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection
M Gisslén, D Fuchs, B Svennerholm, et al.
Journal of Neuroimmunology
|
January 8, 2000
Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients
L Hagberg, D Fuchs, L Rosengren, et al.
Journal of Neuroscience Research
|
March 1, 1991
Cerebrospinal fluid catecholamine metabolites in HIV-infected patients
M Larsson, L Hagberg, A Forsman, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 141) with videos related to
Sort By:
Page
of 15
Lancet (London, England)
|
August 26, 1998
Neurological efficacy of stavudine, zidovudine, and lamivudine
M Gisslén, B Svennerholm, D Fuchs, et al.
Ugeskrift for Laeger
|
April 15, 2000
[Hand transplantation and implantation of nerve chips. New developments within hand surgery]
L Dahlin, J Fridén, L Hagberg, et al.
AIDS Research and Human Retroviruses
|
January 20, 1996
Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection
M Gisslén, P Fredman, G Norkrans, et al.
Journal of Neuroscience Research
|
August 1, 1989
Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection
M Larsson, L Hagberg, G Norkrans, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1989
Immune status and booster effects of low doses of diphtheria toxoid in Swedish medical personnel
B Björkholm, M Wahl, M Granström, et al.
Infection
|
January 1, 1987
An outbreak of diphtheria among Swedish alcoholics
B Björkholm, S Olling, P Larsson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1985
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections
L Hagberg, D E Briles, C S Edén
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 31, 1999
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection
M Gisslén, D Fuchs, B Svennerholm, et al.
Journal of Neuroimmunology
|
January 8, 2000
Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients
L Hagberg, D Fuchs, L Rosengren, et al.
Journal of Neuroscience Research
|
March 1, 1991
Cerebrospinal fluid catecholamine metabolites in HIV-infected patients
M Larsson, L Hagberg, A Forsman, et al.
Page
of 15